Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Taxus Cardium Pharmaceuticals Group Inc (OTC Pink - Limited Information:CRXM)

0.1511
Delayed Data
As of Sep 22
 0.00 / 0.00%
Today’s Change
0.01
Today|||52-Week Range
0.29
-0.83%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$2.2M

Company Description

Taxus Cardium Pharmaceuticals Group, Inc. is regenerative therapeutics company . The company focuses on the late-stage clinical and development of regenerative medicine therapeutics. Its product candidates include Generx, an interventional cardiology, angiogenic gene therapy product candidate designed for the treatment of cardiac microvascular insufficiency due to increasing coronary artery disease; and Excellagen, an acellular biological skin substitute designed as a wound care product for the treatment of chronic non-healing diabetic foot, venous and pressure ulcers. The company was founded by Christopher J. Reinhard and Tyler M. Dylan-Hyde on December 22, 2003 and is headquartered in San Diego, CA.

Contact Information

Taxus Cardium Pharmaceuticals Group, Inc.
11750 Sorrento Valley Road
San Diego California 92121
P:(858) 436-1000
Investor Relations:

Employees

Shareholders

Individual stakeholders1.07%
Mutual fund holders--
Other institutional--

Top Executives

Christopher J. ReinhardChairman, President, CEO, CFO, Treasurer & CAO
Gabor M. RubanyiChief Scientific Officer
Lois A. ChandlerVice President-Biologics Development
Duane M. LinstromSecretary